Weida Chen
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Immune cells in cancer
Papers in
-
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 2
- Histone Deacetylase Inhibitors Research 2
-
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- Xiangdong Meng (1 shared paper)Jianjie Wang (1 shared paper)Shoufeng Wang (1 shared paper)Ning Zhang (1 shared paper)Zhaoming Ye (1 shared paper)Eloy Yinwang (1 shared paper)Jiahao Zhang (1 shared paper)Haochen Mou (1 shared paper)
In The Last Decade
Weida Chen
30 papers receiving 274 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 56
- Immunology 69
- Rehabilitation 13
- Complementary and alternative medicine 13
- Pharmacology 26
Countries citing papers authored by Weida Chen
This map shows the geographic impact of Weida Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weida Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weida Chen more than expected).
Fields of papers citing papers by Weida Chen
This network shows the impact of papers produced by Weida Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weida Chen. The network helps show where Weida Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Weida Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 69 | |
| 2 | 2021 | 41 | |
| 3 | 2021 | 22 | |
| 4 | 2021 | 19 | |
| 5 | 2021 | 16 | |
| 6 | 2022 | 13 | |
| 7 | 2019 | 12 | |
| 8 | 2006 | 10 | |
| 9 | 2019 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2020 | 9 | |
| 12 | [The study of vascular lesion using ultrasound in children with a history of Kawasaki disease]. | 2007 | 6 |
| 13 | 2022 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 2023 | 3 | |
| 20 | Experimental study on assessment of left and right ventricular mass by real-time three-dimensional echocardiography | 2007 | 2 |
About Weida Chen
Weida Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 34 papers that have together received 276 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related molecular mechanisms research (3 papers), Cell Adhesion Molecules Research (2 papers), Circular RNAs in diseases (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Congenital Heart Disease Studies (2 papers). The work is most often cited by research in Cancer Research (56 citations), Immunology (69 citations), Rehabilitation (13 citations), Complementary and alternative medicine (13 citations) and Pharmacology (26 citations). Weida Chen has collaborated with scholars based in China and Czechia. Frequent co-authors include Xiangdong Meng, Jianjie Wang, Shoufeng Wang, Ning Zhang, Zhaoming Ye, Eloy Yinwang, Jiahao Zhang, Haochen Mou, Shan Li and Wenlong Lin. Their work appears in journals such as Scientific Reports, Annals of Translational Medicine, BMC Cardiovascular Disorders, Pharmacogenomics and Applied Surface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.